Jesper Haaning

681 total citations
16 papers, 486 citations indexed

About

Jesper Haaning is a scholar working on Hematology, Rheumatology and Molecular Biology. According to data from OpenAlex, Jesper Haaning has authored 16 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 4 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in Jesper Haaning's work include Hemophilia Treatment and Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). Jesper Haaning is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). Jesper Haaning collaborates with scholars based in Denmark, United States and Germany. Jesper Haaning's co-authors include Lars Sottrup‐Jensen, Claus Oxvig, Michael T. Overgaard, Cheryl A. Conover, Michael Christiansen, Gerald J. Gleich, Inger M. Olsen, Lisbeth S. Laursen, Henning B. Boldt and Gerald J. Gleich and has published in prestigious journals such as Journal of Biological Chemistry, Blood and European Journal of Biochemistry.

In The Last Decade

Jesper Haaning

16 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesper Haaning Denmark 9 155 144 119 107 106 16 486
L. Rom South Africa 12 65 0.4× 64 0.4× 70 0.6× 70 0.7× 43 0.4× 24 379
Shiming Lü China 12 36 0.2× 33 0.2× 133 1.1× 102 1.0× 88 0.8× 25 462
A. Romeu Spain 14 34 0.2× 70 0.5× 69 0.6× 99 0.9× 95 0.9× 29 568
Farah Parveen India 14 11 0.1× 64 0.4× 90 0.8× 162 1.5× 51 0.5× 33 530
C. M. Towler United Kingdom 13 32 0.2× 52 0.4× 108 0.9× 123 1.1× 99 0.9× 17 442
Anita Perricelli United States 6 45 0.3× 26 0.2× 172 1.4× 66 0.6× 160 1.5× 6 710
Joon Cheol Park South Korea 10 52 0.3× 19 0.1× 141 1.2× 148 1.4× 26 0.2× 27 517
Y-M.D. Lo United Kingdom 7 41 0.3× 48 0.3× 167 1.4× 23 0.2× 202 1.9× 9 480
E Neumann Austria 11 95 0.6× 159 1.1× 77 0.6× 9 0.1× 19 0.2× 37 422
Andrzej Malinowski Poland 16 25 0.2× 17 0.1× 148 1.2× 294 2.7× 66 0.6× 130 923

Countries citing papers authored by Jesper Haaning

Since Specialization
Citations

This map shows the geographic impact of Jesper Haaning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Haaning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Haaning more than expected).

Fields of papers citing papers by Jesper Haaning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Haaning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Haaning. The network helps show where Jesper Haaning may publish in the future.

Co-authorship network of co-authors of Jesper Haaning

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Haaning. A scholar is included among the top collaborators of Jesper Haaning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Haaning. Jesper Haaning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Seremetis, Stephanie, et al.. (2020). Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events. Blood. 136(Supplement 1). 40–40. 15 indexed citations
2.
Rode, Frederik, Kasper Almholt, Maj Petersen, et al.. (2018). Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8‐GP) and development of a human pharmacokinetic prediction model. Journal of Thrombosis and Haemostasis. 16(6). 1141–1152. 8 indexed citations
3.
4.
Dolan, G., Elisabeth Steinhagen‐Thiessen, Craig M. Kessler, et al.. (2012). Advances in Hemophilia Care: Report of Two Symposia at the Hemophilia 2010 World Congress. Advances in Therapy. 29(S1). 1–16. 2 indexed citations
5.
Mahlangu, Johnny, Michael Laffan, Jerzy Windyga, et al.. (2012). Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia. Journal of Thrombosis and Haemostasis. 10(5). 773–780. 29 indexed citations
6.
7.
Ivens, Inge A., et al.. (2010). BAY 94–9027, a PEGylated Recombinant Human FVIII, Shows Less Immunogenicity Compared to Un-PEGylated Recombinant FVIII. Blood. 116(21). 2214–2214. 6 indexed citations
8.
Mahlangu, Johnny, Michael Laffan, Jerzy Windyga, et al.. (2010). Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study of the rFVIIa Variant (BAY 86–6150) In Hemophilia A or B with or without Inhibitors.. Blood. 116(21). 3679–3679. 4 indexed citations
9.
Søe, Rikke, Michael T. Overgaard, Anni R. Thomsen, et al.. (2002). Expression of recombinant murine pregnancy‐associated plasma protein‐A (PAPP‐A) and a novel variant (PAPP‐Ai) with differential proteolytic activity. European Journal of Biochemistry. 269(8). 2247–2256. 32 indexed citations
10.
Overgaard, Michael T., Jesper Haaning, Henning B. Boldt, et al.. (2000). Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor. Journal of Biological Chemistry. 275(40). 31128–31133. 150 indexed citations
11.
Overgaard, Michael T., Claus Oxvig, Michael Christiansen, et al.. (1999). Messenger Ribonucleic Acid Levels of Pregnancy-Associated Plasma Protein-A and the Proform of Eosinophil Major Basic Protein: Expression in Human Reproductive and Nonreproductive Tissues1. Biology of Reproduction. 61(4). 1083–1089. 94 indexed citations
12.
Haaning, Jesper, Claus Oxvig, Michael T. Overgaard, & Lars Sottrup‐Jensen. (1997). Simple and reliable procedure for PCR amplification of genomic DNA from yeast cells using short sequencing primers. IUBMB Life. 42(1). 169–172. 5 indexed citations
13.
Nielsen, Peter Kresten, Jesper Haaning, & Lars Sottrup‐Jensen. (1997). Characterisation of bovine structure‐specific recognition protein 1 (SSRP1) cDNA. IUBMB Life. 43(4). 781–786. 2 indexed citations
14.
Haaning, Jesper, Claus Oxvig, Michael T. Overgaard, et al.. (1996). Complete cDNA Sequence of the Preproform of Human Pregnancy‐Associated Plasma Protein‐A. European Journal of Biochemistry. 237(1). 159–163. 22 indexed citations
15.
Oxvig, Claus, Jesper Haaning, Lene Juel Kristensen, et al.. (1995). Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma. Journal of Biological Chemistry. 270(23). 13645–13651. 62 indexed citations
16.
Oxvig, Claus, Jesper Haaning, Peter Højrup, & Lars Sottrup‐Jensen. (1994). Location and nature of carbohydrate groups in proform of human major basic protein isolated from pregnancy serum.. PubMed. 33(2). 329–36. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Rom Breakdown of academic impact, for papers by Shiming Lü Breakdown of academic impact, for papers by A. Romeu Breakdown of academic impact, for papers by Farah Parveen Breakdown of academic impact, for papers by C. M. Towler Breakdown of academic impact, for papers by Anita Perricelli Breakdown of academic impact, for papers by Joon Cheol Park Breakdown of academic impact, for papers by Y-M.D. Lo Breakdown of academic impact, for papers by E Neumann Breakdown of academic impact, for papers by Andrzej Malinowski
Rankless by CCL
2026